In a murine breast cancer model, Fli1 was shown to act as a tumor suppressor [26], but studies examining human breast cancer showed that FLI1 enhances tumor properties [24, 25] and that its expression correlates with poor prognostic factors such as lymph node metastasis and poor differentiation [25]. Here, FLI1 is linked to breast carcinoma.